IRF7 and infection: Some mice that lost >8% body weight and then recovered had persistent lesions detectable at the latest time point sampled (up to day 32 for C57BL/6J and day 21 for Irf7−/−) (Supplementary Fig. 11B), consistent with persistent neurological sequelae in humans that survive infection.